(redirected from Betapace)
Also found in: Medical.
Related to Betapace: Betapace AF, Tobramycin sulfate


 (sō′tə-lôl′, -lōl′)
A beta-blocker drug, C12H20N2O3S, used in its hydrochloride form to treat certain cardiac arrhythmias.

[Alteration of sorta (because sotalol is only "sort of" a beta-blocker, since it also has antiarrhythmic effects related to the cellular transport of potassium ions) + (proprano)lol.]


n sotalol m
References in periodicals archive ?
Sotalol hydrochloride is the active ingredient in Betapace AF, a treatment for irregular heart rhythms made by Schering AG unit Berlex Inc.
Other launches during 2004 include seven strengths of Amphetamines Mixed Salts tablets (reference: Adderall tablets, Shire Pharmaceuticals Group), Sotalol AF tablets (reference: Betapace AF tablets, Berlex Laboratories), Phentermine 37.
Berlex Laboratories, which markets the drug as Betapace, filed a supplemental application for approval of this indication.